BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35885920)

  • 1. Gene-Environment Correlation over Time: A Longitudinal Analysis of Polygenic Risk Scores for Schizophrenia and Major Depression in Three British Cohorts Studies.
    Machlitt-Northen S; Keers R; Munroe PB; Howard DM; Pluess M
    Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic scores for schizophrenia and major depression are associated with psychosocial risk factors in children: evidence of gene-environment correlation.
    Machlitt-Northen S; Keers R; Munroe PB; Howard DM; Trubetskoy V; Pluess M
    J Child Psychol Psychiatry; 2022 Oct; 63(10):1140-1152. PubMed ID: 35781881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polygenic risk scores for schizophrenia and major depression are associated with socio-economic indicators of adversity in two British community samples.
    Machlitt-Northen S; Keers R; Munroe PB; Howard DM; Pluess M
    Transl Psychiatry; 2022 Nov; 12(1):477. PubMed ID: 36376270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures.
    Harris MA; Shen X; Cox SR; Gibson J; Adams MJ; Clarke TK; Deary IJ; Lawrie SM; McIntosh AM; Whalley HC
    Psychol Med; 2020 Jul; 50(10):1653-1662. PubMed ID: 31317844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic interactions with environmental adversity in the aetiology of major depressive disorder.
    Mullins N; Power RA; Fisher HL; Hanscombe KB; Euesden J; Iniesta R; Levinson DF; Weissman MM; Potash JB; Shi J; Uher R; Cohen-Woods S; Rivera M; Jones L; Jones I; Craddock N; Owen MJ; Korszun A; Craig IW; Farmer AE; McGuffin P; Breen G; Lewis CM
    Psychol Med; 2016 Mar; 46(4):759-70. PubMed ID: 26526099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.
    Sewell MDE; Jiménez-Sánchez L; Shen X; Edmondson-Stait AJ; Green C; Adams MJ; Rifai OM; McIntosh AM; Lyall DM; Whalley HC; Lawrie SM
    Brain Behav Immun; 2021 Oct; 97():32-41. PubMed ID: 34107350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.
    Fanelli G; Benedetti F; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110170. PubMed ID: 33181205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polygenic Risk for Schizophrenia, Major Depression, and Post-traumatic Stress Disorder and Hippocampal Subregion Volumes in Middle Childhood.
    Pine JG; Paul SE; Johnson E; Bogdan R; Kandala S; Barch DM
    Behav Genet; 2023 May; 53(3):279-291. PubMed ID: 36720770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
    Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
    J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing the polygenic overlaps of bipolar disorder subtypes with schizophrenia and major depressive disorder.
    Li Z; Li D; Chen X
    J Affect Disord; 2022 Jul; 309():242-251. PubMed ID: 35487438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.
    Liebers DT; Pirooznia M; Seiffudin F; Musliner KL; Zandi PP; Goes FS
    Schizophr Bull; 2016 Jul; 42(4):984-91. PubMed ID: 26873889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial aggregation and shared genetic loading for major psychiatric disorders and type 2 diabetes.
    Su MH; Shih YH; Lin YF; Chen PC; Chen CY; Hsiao PC; Pan YJ; Liu YL; Tsai SJ; Kuo PH; Wu CS; Huang YT; Wang SH
    Diabetologia; 2022 May; 65(5):800-810. PubMed ID: 35195735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Clinical Characteristics to Identify Which Patients With Major Depressive Disorder Have a Higher Genetic Load for Three Psychiatric Disorders.
    Verduijn J; Milaneschi Y; Peyrot WJ; Hottenga JJ; Abdellaoui A; de Geus EJC; Smit JH; Breen G; Lewis CM; Boomsma DI; Beekman ATF; Penninx BWJH
    Biol Psychiatry; 2017 Feb; 81(4):316-324. PubMed ID: 27576130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.
    Postolache TT; Del Bosque-Plata L; Jabbour S; Vergare M; Wu R; Gragnoli C
    Am J Med Genet B Neuropsychiatr Genet; 2019 Apr; 180(3):186-203. PubMed ID: 30729689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of polygenic risk scores on depression in childhood trauma.
    Peyrot WJ; Milaneschi Y; Abdellaoui A; Sullivan PF; Hottenga JJ; Boomsma DI; Penninx BW
    Br J Psychiatry; 2014 Aug; 205(2):113-9. PubMed ID: 24925986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of schizophrenia and mood disorder risk alleles on emotional problems: investigating change from childhood to middle age.
    Riglin L; Collishaw S; Richards A; Thapar AK; Rice F; Maughan B; O'Donovan MC; Thapar A
    Psychol Med; 2018 Oct; 48(13):2153-2158. PubMed ID: 29239291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EXPLORATORY ANALYSIS OF POLYGENIC RISK SCORES FOR PSYCHIATRIC DISORDERS: APPLIED TO DUAL DIAGNOSIS.
    Martínez-Magaña JJ; Gonzalez-Castro TB; Genís-Mendoza AD; Tovilla-Zárate CA; Juárez-Rojop IE; Saucedo-Uribe E; Rodríguez-Mayoral O; Lanzagorta N; Escamilla M; Macías-Kauffer L; Nicolini H
    Rev Invest Clin; 2019; 71(5):321-329. PubMed ID: 31599879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response.
    Fanelli G; Domschke K; Minelli A; Gennarelli M; Martini P; Bortolomasi M; Maron E; Squassina A; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; De Ronchi D; Baune BT; ; Serretti A; Fabbri C
    Eur Neuropsychopharmacol; 2022 Feb; 55():86-95. PubMed ID: 34844152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuity of genetic and environmental influences on clinically assessed major depression from ages 18 to 45.
    Torvik FA; Gustavson K; Ystrom E; Rosenström TH; Gillespie N; Reichborn-Kjennerud T; Kendler KS
    Psychol Med; 2019 Nov; 49(15):2582-2590. PubMed ID: 30484418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.
    Pries LK; Dal Ferro GA; van Os J; Delespaul P; Kenis G; Lin BD; Luykx JJ; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Şahin Cankurtaran E; Ulusoy Kaymak S; Mihaljevic MM; Andric Petrovic S; Mirjanic T; Bernardo M; Mezquida G; Amoretti S; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Can Saka M; ; Arango C; O'Donovan M; Tosato S; Rutten BPF; Guloksuz S
    Epidemiol Psychiatr Sci; 2020 Nov; 29():e182. PubMed ID: 33200977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.